You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 27, 2011

Thailand Joins Forces with WHO, Interpol Task Force to Fight Invasion of Counterfeit Drugs

PharmAsia News

Thailand’s pharmaceutical industry is helping inform the citizenry about the dangers of counterfeit medicines as the country joins forces with groups including Interpol, the World Health Organization’s Anticounterfeiting taskforce, and the United States Pharmacopeia to combat an invasion of fake drugs. Tilleke & Gibbins consultant Clemence Gautier was interviewed for the article.

RELATED INSIGHTS​ 

October 13, 2016
Tilleke & Gibbins, together with EuroCham Vietnam, will hold a seminar focusing on legal issues in the pharmaceutical sector. The seminar will feature a panel of pharmaceutical and intellectual property experts from Japan, Thailand, and Vietnam, and it will provide attendees with an in-depth look at emerging issues in Vietnam’s rapidly developing pharmaceutical sector, including:
May 6, 2016
The key drivers of healthcare product investment are the effective protection of intellectual property rights and compliance with the law. Protection of IP rights and obtaining market authorization are challenges faced by every company operating in the healthcare industry. To discuss these issues and more, Dr. Atthachai Homhuan, regulatory affairs manager at Tilleke & Gibbins, will present on “Intellectual Property and Regulatory Perspectives of Thailand’s Healthcare Business” at an IP Lunch Talk held by Tilleke & Gibbins and the National Innovation Agency.
April 28, 2016
The nominees of Asian Legal Business’s Southeast Asia Law Awards 2016 have been announced, and Tilleke & Gibbins has secured nominations in three categories, as follows:Intellectual Property Firm of the YearThailand Law Firm of the YearVietnam Law Firm of the YearTo determine the winners, a team of researchers at ALB are considering factors such as firms’ breadth and complexity of work, innovation, third-party awards, and market feedback, among other criteria.